Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9880469dc8f12dad7c3ad95c6ab31fe |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 |
filingDate |
2017-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01a322d2d031c7150d4befc55058c316 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ede95e276f4ca1c373cf484f6a1b6fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2e911a024de90e254def51f5126680 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2000c45870aca108e3899fb1ea6e06df |
publicationDate |
2017-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017354657-A1 |
titleOfInvention |
Method of treating pancreatic cancer |
abstract |
The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021346361-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019269664-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019275015-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113350509-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11517622-B2 |
priorityDate |
2016-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |